Compound 1b

(32S,2R,9S,15S)-15-benzyl-2-ethyl-9-isobutyl-5,8,11,14-tetraaza-1(2,5)-oxadiazola-3(1,2)-pyrrolidinacyclopentadecaphane-4,7,10,13-tetraone

From: Oxadiazole grafts in peptide macrocycles

View in PubChem | HPLC | 1H NMR | 13C NMR | MDL Molfile | ChemDraw

Synonyms:
  • cyclo[PGLGF]odz/(R,S)-ethyl

Synthetic procedure: See article for the definitive version of this procedure and for full experimental details.

The peptide NH-Pro-Gly-Leu-Gly-Phe-CO2H (24.5 mg, 0.05 mmol, 1 eq) was dissolved in a mixture of 1:1 dichloroethane:acetonitrile (1 mL). Propionaldehyde (5.4 μL, 0.075 mmol, 1.5 eq) and (N-isocyanimino)triphenylphosphorane (15.1 mg, 0.05 mmol, 1 eq) were added to the reaction mixture. After cyclization and reverse phase purification the pure fractions were pooled and lyophilized to afford 14mg of the title compound major diastereomer 1a (50% yield) and 5 mg of the minor diastereomer 1b (18 % yield) for a total 68% overall yield. Minor (R,S)- 1b: HR-MS (ESI) calculated for C28H40N7O5[M+H]+: 554.3085found: 554.3083. HPLC method used was the same as applied in the purification of 1a, retention time 8.15 min.